Concepedia

Heidi L. Kenerson

HL

36

Publications

2.3K

Citations

27

H-Index

2002

Active since

Affiliations

University of Washington(Current)

Fred Hutch Cancer Center

University of Washington Medical Center

Seattle University

Institute for Systems Biology

Heidi L. Kenerson is an author at University of Washington specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

2002–2024

36

Publications

36

Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.

Heidi L. Kenerson, Lauri D. Aicher, Lawrence D. True et al. · PubMed · 2002 · 281 citations

, , +20

Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms

Heidi L. Kenerson, Andrew L. Folpe, Thomas K. Τakayama et al. · Human Pathology · 2007 · 247 citations · Full text

, , +6

Effects of Rapamycin in the Eker Rat Model of Tuberous Sclerosis Complex

Heidi L. Kenerson, Trevor A. Dundon, Raymond S. Yeung · Pediatric Research · 2004 · 163 citations · Full text

, , +8

Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

Kevin M. Sullivan, Xiuyun Jiang, Prajna Guha et al. · Gut · 2022 · 124 citations · Full text

Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells Activates Hypoxia-Induced Factors

Patrick A. Carroll, Heidi L. Kenerson, Raymond S. Yeung et al. · Journal of Virology · 2006 · 113 citations · Full text

, , +21

Rows per page

1–5 of 36